Google Maps

U.S. Server Location

Executive Assistant to President & CEO

Elyse Trockman

Chief People Officer

Marcie Cain

Chief Operating Officer

Sujal Bhalakia

Interim Chief Commercial Officer

Veena Rao

Vice President of Operations

David Henderson

Vice President, Clinical and Regulatory Affairs

Doug Ferguson

Operations

Firas El-Khatib

Vice President of Sales

Hokan Ojert

VP of Quality

Joe Conkey

VP of Marketing

Karen Hynes

Beth A Brooke-Marciniak

Gilad Glick

VP, Autonomous Systems

Ed Damiano

Founder and Executive Chair

Vice President Business Development

Mike Rosinko

Chief Technology Officer

Toby Milgrome

Co-Founder

Tony Galliani

Vice President, Commercial Strategy

Sean Saint

Chief Executive Officer

Biotechnology Companies With More Than 100 Employees

United States Medical Device Female Founded Companies

Greater Los Angeles Area Late Stage Companies With More Than $10M in Revenue

United States Companies With More Than 10 Employees (Top 10K)

Beta Bionics is a biotechnology company that develops an integrated bionic pancreas system called the iLet. The iLet Bionic Pancreas System was granted breakthrough designation in all configurations (insulin-only, glucagon-only, and bihormonal), including use with Zealand Pharma’s dasiglucagon, a glucagon analogue with a stability profile in a ready-to-use aqueous solution. It also offers a bionic pancreas device for glucose metabolism to the diabetes community.

Wellington Management

Series E - Beta Bionics

Omega Funds

Sands Capital Ventures

Series D - Beta Bionics

Eventide

Farallon Capital Management

Perceptive Advisors

RTW Investments

Soleus Capital

Series C - Beta Bionics

Series B - Beta Bionics

National Institute of Diabetes and Digestive and Kidney Diseases

Grant - Beta Bionics

Venture Round - Beta Bionics

Equity Crowdfunding - Beta Bionics

Eli Lilly

Novo Nordisk

Series A - Beta Bionics

Irvine

California

United States

North America

Beta Bionics

The Week’s Biggest Funding Rounds: Food Delivery Startup Wonder Leads Big Week

Beta Bionics Closes $60M Series E Financing

Beta Bionics Announces Closing of a $60 Million Series E Financing

Beta Bionics Announces Partnership With Abbott to Integra...

Beta Bionics Celebrates Milestone: 10,000th iLet Patient

Xeris Enters Into an Exclusive Worldwide Collaboration and License Agreement with Beta Bionics

Xeris Biopharma, Beta Bionics team up for diabetes pum By Investing.com

An insulin delivery system designed to autonomously manage and administer insulin doses based on continuous glucose monitoring data.

Allows the iLet Bionic Pancreas to integrate with Dexcom G7 for continuous glucose monitoring, enabling real-time insulin dose adjustments.

Supports the use of prefilled insulin cartridges, offering users convenience and choice among different insulin types.

India

Asia

Switzerland

Europe

Singapore

Mexico

HTML5

Vimeo

Apache Server

Google Analytics

Google Tag Manager

Google Fonts

GreenSock Animation Platform

Adobe Fonts

Google Compute Engine

Beta Bionics is dedicated to addressing the immense cognitive and emotional burden of managing type 1 diabetes by developing advanced technology solutions for consistent glycemic control.

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general	Mar 7, 2024 4:21 AM	4f73c6b6
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Mar 7, 2024 4:21 AM	bdd1103e
company summary	general
signals	general
crunchbase trigger	general	Nov 25, 2024 9:06 AM	f7d191ee
crunchbase profile	general	Nov 25, 2024 9:42 AM	c72e14a4
li profile	general
translate crunchbase fundingrounds	general	Nov 25, 2024 1:52 PM	88b5755c
peers	general
news basic	general	Mar 7, 2024 4:21 AM	b299713b
bundesanzeiger	filings
financials download nd	financials
private financials	financials

BETA

COM:BETABIONICS

Beta Bionics